← Open Payments lookup

JACOB BOLLINGER: Open Payments

NPI 1952944316 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$894 in 43 payments from 13 companies in 2025. Trend: 2023 $365 · 2024 $523 · 2025 $894

Food & beverage: $804Education: $90
CompanyPaymentsAmount
Lilly USA, LLC11$280
Amgen Inc.7$149
Novo Nordisk Inc8$138
PFIZER INC.3$76
Takeda Pharmaceuticals U.S.A., Inc.4$63
Dexcom, Inc.2$37
Exact Sciences Corporation2$36
Boston Scientific Corporation1$27
Sumitomo Pharma America, Inc.1$23
AstraZeneca Pharmaceuticals LP1$18

Products named: MOUNJARO, Wegovy, REPATHA, OTEZLA, TRINTELLIX, ELIQUIS, Dexcom G6 Transmitter, Cologuard Collection Kit.

Industry payments across MD — which companies pay providers there.